Home Health Talk NAFDAC Gives Update On The Withdrawal Sildenafil And Trazodone Tablets

NAFDAC Gives Update On The Withdrawal Sildenafil And Trazodone Tablets

487

The National Agency for Food and Drug Administration and Control has been stated in a post that information reached it from the United States Food and Drug Administration of the recall of Sildenafil 100mg tablets and Trazodone 100mg tablets due to product mix-up. 

NAFDAC
NAFDAC

According to NAFDAC, the Sildenafil 100mg and Trazodone 100mg tablets were inadvertently packaged together during bottling.

 Sildenafil is used to treat erectile dysfunction and is likely to cause serious health risks if consumed by persons with underlying medical issues.

Trazodone hydrochloride is used to treat major depressive disorder, the unintentional use of the medicine may cause adverse health consequences.

NAFDAC has in a post charged Importers, wholesalers, and retailers to stop the importation, distribution, and use of the recalled Sildenafil 100mg tablets and Trazodone 100mg tablets.

NAFDAC has charged Patients already using the affected Sildenafil 100mg tablets and Trazodone 100mg tablets to discontinue it’s use and consult their healthcare provider.

NAFDAC has therefore advised Patients and healthcare providers to report adverse effects experienced from using these products to the nearest NAFDAC office.

LEAVE A REPLY

Please enter your comment!
Please enter your name here